Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis

Panisset, Maya G.; Kilpatrick, Trevor J.; Lizama, LE Cofré; Galea, MP

doi:10.1016/j.msard.2022.103933

Cited by 5 publications

(5 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is a well-established link between positive vaccine attitudes in health care providers (HCPs) and an increased rate of vaccine uptake in their patients [ 57 , 58 , 59 ]. The more overall positive vaccine attitudes that a provider has, the more the provider recommends it to patients, family, and friends [ 60 ].…”

Section: Health Care Professionalsmentioning

confidence: 99%

Factors Affecting Vaccine Attitudes Influenced by the COVID-19 Pandemic

et al. 2023

View full text Add to dashboard Cite

The development of vaccines has significantly contributed to the success of disease prevention. However, there has been a sharp decline in immunization rates since COVID-19 spread globally. Seemingly overnight, the world shut down and most non-essential medical procedures were postponed. Since the COVID-19 vaccine became available, and the world started going back to normal these vaccine rates have not recovered. In this paper, we review the published literature to explore how convenience factors, perceived risk of vaccination, media or anti-vaccination ideals/movements, and healthcare professionals affect an individual’s compliance to be vaccinated to better understand the factors that contribute to the change in overall vaccination rates.

show abstract

Section: Health Care Professionalsmentioning

confidence: 99%

Factors Affecting Vaccine Attitudes Influenced by the COVID-19 Pandemic

et al. 2023

View full text Add to dashboard Cite

show abstract

“…It has been previously reported that people with MS have concerns about the impact of the vaccine on disease relapse or progression [ 9 , 22 , 23 ]. Fear about reduced DMT efficacy and lack of DMT interaction knowledge has also been cited [ 23 , 24 , 25 , 26 ]. While one study has reported that participants taking DMT were more likely to be vaccinated than those who were not [ 27 ].…”

Section: Discussionmentioning

confidence: 99%

“…Advice from a healthcare provider has been related to being more accurately informed and having greater intent to get COVID-19 [ 23 , 26 , 29 ]. In our study, approximately 71% of participants who were not vaccinated reported that they were likely or unsure if they would accept a COVID-19 vaccination.…”

Section: Discussionmentioning

confidence: 99%

“…The importance of shared doctor-patient decision-making is well established [ 30 ]. Additionally, people with MS who had discussed COVID-19 vaccination with a healthcare provider reported significantly higher intention of vaccine uptake [ 26 ]. This is highlighted in research that found some people with MS delay COVID-19 vaccination until they receive advice from their neurologist [ 22 , 23 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis

et al. 2023

View full text Add to dashboard Cite

Background: People with multiple sclerosis (MS) are susceptible to severe COVID-19 outcomes. They were included as a priority group for the Australian COVID-19 vaccine roll-out in early 2021. However, vaccine hesitancy remains a complex barrier to vaccination in this population group, which may be partly related to disease relapse concerns following COVID-19 vaccination. This study examined the COVID-19 vaccination status, intent, hesitancy, and disease-related beliefs in people with MS. Methods: An online survey was conducted with people with MS receiving care at two Australian health services between September and October 2021. It collected sociodemographic and disease-specific characteristics and responses to validated scales that assessed vaccine hesitancy and general and MS-related vaccine beliefs. Results: Of the 281 participants [mean age 47.7 (SD 12.8) years; 75.8% females], most (82.9%) had received at least one COVID-19 vaccine dose. Younger participants were less likely to be vaccinated, as were those within 1–5 years of disease duration. After controlling for age, disease duration was not associated with vaccination status. Unvaccinated participants were more likely to report less willingness to receive the COVID-19 vaccine, higher vaccine complacency and lower vaccine confidence, greater MS-related vaccine complacency, and higher MS and treatment interaction concerns. Conclusions: People with MS reported a high vaccination rate, despite general and MS-specific COVID-19 vaccine concerns. Greater MS-specific concerns were reported by those who indicated that their MS was not well-controlled and their MS impacted their daily activities. By understanding the factors that influence vaccine hesitancy and their interplay with MS disease course and treatment concerns, this can inform tailored interventions and educational messages to address these concerns in people with MS. Clinicians, governments, and community organisations are key partners in delivering these interventions and messages, as ongoing booster doses are needed for this vulnerable population.

show abstract

“…COVID-19 has raised concerns for them, particularly those receiving disease-modifying therapies (8)(9)(10)(11). During the pandemic, severe limitations (closure of educational and cultural centers, restrictions on service facilities, and social distancing) were imposed to reduce the rapid spread of COVID-19 (12,13).…”

mentioning

confidence: 99%

Experiences Related to the Injection of COVID-19 Vaccines in Patients with Multiple Sclerosis: A Qualitative Study

Rahmatian,

Jamshidbeigi,

Molavi

et al. 2023

Arch Neurosci

View full text Add to dashboard Cite

Background: Multiple sclerosis (MS) is the most common debilitating chronic autoimmune and inflammatory disorder of the central nervous system. Compared to the general population, MS patients are at a higher risk of contracting various diseases. Objectives: This study aimed to determine the challenges related to the injection of COVID-19 vaccines in people with MS. Methods: In this qualitative research that was conducted on patients with MS, the data were collected in a secure environment through semi-structured interviews. We continued the interviews until data saturation, which was reached after 10 interviews, but 2 more interviews were conducted to make sure of data saturation. The duration of each interview was 30 - 45 minutes, depending on each patient's condition. The data were managed in MAXQDA 10. Results: Of the participants, 66% were female, and the average age of the patients was 47 years. After analyzing the interviews, 4 main categories and 19 subcategories were extracted: mental concerns (hearing rumors, hearing news of death due to COVID-19, worrying about the unknowns of new vaccines, and worrying about side effects and treatment interactions), quarantine suffering (movement complications, depression, weak immune system, social distancing, and compliance with health protocols), educational resources (doctors, clinic staff, national media, cyberspace, and family) and personal experiences (effectiveness of the COVID-19 vaccine, reduction of symptoms compared to unvaccinated people, and having no complications). Conclusions: It is essential to take measures to decrease the existing challenges. For example, the patients were afraid of drug interactions and the lack of full understanding of the disease by doctors. In general, they had many questions, while they did not know a reliable source of information. They chose doctors as the most reliable source; this choice shows the importance and capacity of the doctor's position in relation to vaccination, which can be used to explain and promote vaccination in schools, offices, factories, and other parts of society. Besides, in relation to research on new diseases, a task force should be formed for each disease, and the mutual impacts of diseases and their drug interactions should be investigated; in this way, fewer concerns and problems arise during vaccination and treatment.

show abstract

Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis

Cited by 5 publications

References 46 publications

Factors Affecting Vaccine Attitudes Influenced by the COVID-19 Pandemic

Factors Affecting Vaccine Attitudes Influenced by the COVID-19 Pandemic

COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis

Experiences Related to the Injection of COVID-19 Vaccines in Patients with Multiple Sclerosis: A Qualitative Study

Contact Info

Product

Resources

About